Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Radiopharmaceutical Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100418966C details a novel synthesis for long-half-life PBR imaging agents, offering reliable supply and cost reduction in PET tracer manufacturing.
Novel FAK-targeting compounds and F-18 radiolabels. Efficient synthesis routes for tumor diagnosis and therapy intermediates.